{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:41:05Z","timestamp":1791294065228,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11655-025-3832-y","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T01:57:19Z","timestamp":1749866239000},"page":"877-888","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pseudolaric Acid B Alleviates Non-alcoholic Fatty Liver Disease by Targeting PPAR\u03b1 to Regulate Lipid Metabolism and Promote Mitochondrial Biogenesis"],"prefix":"10.1007","volume":"31","author":[{"given":"Shu-yan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gai","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-xue","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-shen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"key":"3832_CR1","doi-asserted-by":"publisher","first-page":"1087260","DOI":"10.3389\/fendo.2022.1087260","volume":"13","author":"L Rong","year":"2022","unstructured":"Rong L, Zou J, Ran W, Qi X, Chen Y, Cui H, et al. Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD). Front Endocrinol (Lausanne) 2022;13:1087260.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3832_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","volume":"19","author":"JV Lazarus","year":"2022","unstructured":"Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol 2022;19:60\u201378.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3832_CR3","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.3390\/nu15173779","volume":"15","author":"Y Nam","year":"2023","unstructured":"Nam Y, Kim M, Erdenebileg S, Cha KH, Ryu DH, Kim HY, et al. Sanguisorba officinalis L. ameliorates hepatic steatosis and fibrosis by modulating oxidative stress, fatty acid oxidation, and gut microbiota in CDAHFD-induced mice. Nutrients 2023;15:3779.","journal-title":"Nutrients"},{"key":"3832_CR4","doi-asserted-by":"publisher","first-page":"17514","DOI":"10.3390\/ijms242417514","volume":"24","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Zhou Y, Wang D, Huang Z, Xiao X, Zheng Q, et al. Mitochondrial dysfunction in metabolic dysfunction fatty liver disease (MAFLD). Int J Mol Sci 2023;24:17514.","journal-title":"Int J Mol Sci"},{"key":"3832_CR5","doi-asserted-by":"publisher","first-page":"102008","DOI":"10.1016\/j.jbc.2022.102008","volume":"298","author":"L Chen","year":"2022","unstructured":"Chen L, Li Y, Sottas C, Lazaris A, Petrillo SK, Metrakos P, et al. Loss of mitochondrial ATPase ATAD3A contributes to nonalcoholic fatty liver disease through accumulation of lipids and damaged mitochondria. J Biol Chem 2022;298:102008.","journal-title":"J Biol Chem"},{"key":"3832_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","volume":"21","author":"C Koliaki","year":"2015","unstructured":"Koliaki C, Szendroedi J, Kaul K, Jelenik T, Nowotny P, Jankowiak F, et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab 2015;21:739\u2013746.","journal-title":"Cell Metab"},{"key":"3832_CR7","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","volume":"62","author":"M Pawlak","year":"2015","unstructured":"Pawlak M, Lefebvre P, Staels B. Molecular mechanism of PPAR \u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J Hepatol 2015;62:720\u2013733.","journal-title":"J Hepatol"},{"key":"3832_CR8","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1021\/jf0580364","volume":"53","author":"AM Rimando","year":"2005","unstructured":"Rimando AM, Nagmani R, Feller DR, Yokoyama W. Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. J Agric Food Chem 2005;53:3403\u20133407.","journal-title":"J Agric Food Chem"},{"key":"3832_CR9","doi-asserted-by":"publisher","first-page":"118888","DOI":"10.1016\/j.lfs.2020.118888","volume":"266","author":"J Yan","year":"2021","unstructured":"Yan J, Song K, Bai Z, Ge RL. WY14643 improves left ventricular myocardial mitochondrial and systolic functions in obese rats under chronic persistent hypoxia via the PPAR \u03b1 pathway. Life Sci 2021;266:118888.","journal-title":"Life Sci"},{"key":"3832_CR10","first-page":"195","volume":"22","author":"Z Luo","year":"2024","unstructured":"Luo Z, Yin F, Wang X, Kong L. Progress in approved drugs from natural product resources. Chin J Nat Med 2024;22:195\u2013211.","journal-title":"Chin J Nat Med"},{"key":"3832_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/BF02975138","volume":"28","author":"XF Gong","year":"2005","unstructured":"Gong XF, Wang MW, Tashiro S, Onodera S, Ikejima T. Pseudolaric acid B induces apoptosis through p53 and Bax\/Bcl-2 pathways in human melanoma A375-S2 cells. Arch Pharm Res 2005;28:68\u201372.","journal-title":"Arch Pharm Res"},{"key":"3832_CR12","doi-asserted-by":"publisher","first-page":"138715","DOI":"10.1016\/j.foodchem.2024.138715","volume":"445","author":"X Tian","year":"2024","unstructured":"Tian X, Wang X, Xu W, Gong M, Zhou C, Jiang E, et al. Penthorum chinense Pursh leaf tea debittering mechanisms via green tea manufacturing process and its influence on NAFLD-alleviation activities. Food Chem 2024;445:138715.","journal-title":"Food Chem"},{"key":"3832_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.intimp.2018.03.041","volume":"59","author":"T Li","year":"2018","unstructured":"Li T, Wang W, Li YX, Li X, Ji WJ, Ma YQ, et al. Pseudolaric acid B attenuates atherosclerosis progression and inflammation by suppressing PPAR \u03b3-mediated NF-\u03ba B activation. Int Immunopharmacol 2018;59:76\u201385.","journal-title":"Int Immunopharmacol"},{"key":"3832_CR14","doi-asserted-by":"publisher","first-page":"7918","DOI":"10.1038\/s41598-017-08485-x","volume":"7","author":"Z Yang","year":"2017","unstructured":"Yang Z, Liu M, Wang W, Wang Y, Cao B, Gao Y, et al. Pseudolaric acid B attenuates atopic dermatitis-like skin lesions by inhibiting interleukin-17-induced inflammation. Sci Rep 2017;7:7918.","journal-title":"Sci Rep"},{"key":"3832_CR15","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.3390\/ijms24032844","volume":"24","author":"X Yin","year":"2023","unstructured":"Yin X, Guo X, Liu Z, Wang J. Advances in the diagnosis and treatment of non-alcoholic fatty liver disease. Int J Mol Sci 2023;24:2844.","journal-title":"Int J Mol Sci"},{"key":"3832_CR16","doi-asserted-by":"publisher","first-page":"110155","DOI":"10.1016\/j.biopha.2020.110155","volume":"127","author":"Z Xie","year":"2020","unstructured":"Xie Z, Gao G, Wang H, Li E, Yuan Y, Xu J, et al. Dehydroabietic acid alleviates high fat diet-induced insulin resistance and hepatic steatosis through dual activation of PPAR-\u03b3 and PPAR-\u03b1. Biomed Pharmacother 2020;127:110155.","journal-title":"Biomed Pharmacother"},{"key":"3832_CR17","first-page":"1552","volume":"30","author":"Q Li","year":"2014","unstructured":"Li Q, Dong XQ, Wang YT, et al. Pharmacodynamic analysis and related mechanisms of pseudolaric acid B on contact hypersensitivity. Chin Pharmacol Bull (Chin) 2014;30:1552\u20131557.","journal-title":"Chin Pharmacol Bull (Chin)"},{"key":"3832_CR18","doi-asserted-by":"publisher","first-page":"155313","DOI":"10.1016\/j.phymed.2023.155313","volume":"128","author":"G Gao","year":"2023","unstructured":"Gao G, Zhao J, Ding J, Liu S, Shen Y, Liu C, et al. Alisol B regulates AMPK\/mTOR\/SREBPs via directly targeting VDAC1 to alleviate hyperlipidemia. Phytomedicine 2023;128:155313.","journal-title":"Phytomedicine"},{"key":"3832_CR19","doi-asserted-by":"publisher","first-page":"154711","DOI":"10.1016\/j.phymed.2023.154711","volume":"112","author":"ZS Xie","year":"2023","unstructured":"Xie ZS, Zhao JP, Wu LM, Chu S, Cui ZH, Sun YR, et al. Hederagenin improves Alzheimer\u2019s disease through PPAR \u03b1\/TFEB-mediated autophagy. Phytomedicine 2023;112:154711.","journal-title":"Phytomedicine"},{"key":"3832_CR20","doi-asserted-by":"publisher","first-page":"116243","DOI":"10.1016\/j.jep.2023.116243","volume":"307","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhao L, Xiang S, Sun Y, Wang P, Chen JJ, et al. Yishen Tongluo Formula alleviates diabetic kidney disease through regulating Sirt6\/TGF-\u03b2 1\/Smad2\/3 pathway and promoting degradation of TGF-\u03b2 1. J Ethnopharmacol 2023;307:116243.","journal-title":"J Ethnopharmacol"},{"key":"3832_CR21","doi-asserted-by":"publisher","first-page":"100301","DOI":"10.1016\/j.clinsp.2023.100301","volume":"78","author":"SH Tan","year":"2023","unstructured":"Tan SH, Zhou XL. Early-stage non-alcoholic fatty liver disease in relation to atherosclerosis and inflammation. Clinics (Sao Paulo) 2023;78:100301.","journal-title":"Clinics (Sao Paulo)"},{"key":"3832_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1055\/s-0041-1725022","volume":"41","author":"S M\u00f8ller","year":"2021","unstructured":"M\u00f8ller S, Kimer N, Kronborg T, Grandt J, Hove JD, Barl\u00f8se M, et al. Nonalcoholic fatty liver disease and cardiovascular disease: overlapping mechanisms. Semin Liver Dis 2021;41:235\u2013247.","journal-title":"Semin Liver Dis"},{"key":"3832_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-023-01415-6","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li Z, Liu X, Chen X, Zhang S, Chen Y, et al. 3-Hydroxybutyrate ameliorates insulin resistance by inhibiting PPAR \u03b3 Ser273 phosphorylation in type 2 diabetic mice. Signal Transduct Target Ther 2023;8:190.","journal-title":"Signal Transduct Target Ther"},{"key":"3832_CR24","doi-asserted-by":"publisher","first-page":"1074911","DOI":"10.3389\/fendo.2022.1074911","volume":"13","author":"Y Lin","year":"2022","unstructured":"Lin Y, Wang Y, Li PF. PPAR \u03b1: an emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases. Front Endocrinol (Lausanne) 2022;13:1074911.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3832_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jmb.2009.03.024","volume":"388","author":"T Degenhardt","year":"2009","unstructured":"Degenhardt T, V\u00e4is\u00e4nen S, Rakhshandehroo M, Kersten S, Carlberg C. Peroxisome proliferator-activated receptor alpha controls hepatic heme biosynthesis through ALAS1. J Mol Biol 2009;388:225\u2013238.","journal-title":"J Mol Biol"},{"key":"3832_CR26","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1073\/pnas.0808742106","volume":"106","author":"A Billon-Gal\u00e9s","year":"2009","unstructured":"Billon-Gal\u00e9s A, Fontaine C, Filipe C, Douin-Echinard V, Fouque MJ, Flouriot G, et al. The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiol. Proc Natl Acad Sci U S A 2009;106:2053\u20132058.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3832_CR27","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1007\/s11030-022-10587-2","volume":"27","author":"S Ballav","year":"2023","unstructured":"Ballav S, Lokhande KB, Yadav RS, Ghosh P, Swamy KV, Basu S. Exploring binding mode assessment of novel kaempferol, resveratrol, and quercetin derivatives with PPAR-\u03b1 as potent drug candidates against cancer. Mol Divers 2023;27:2867\u20132885.","journal-title":"Mol Divers"},{"key":"3832_CR28","doi-asserted-by":"publisher","first-page":"7623","DOI":"10.1038\/s41598-020-64527-x","volume":"10","author":"T Yoshida","year":"2020","unstructured":"Yoshida T, Oki H, Doi M, Fukuda S, Yuzuriha T, Tabata R, et al. Structural basis for PPAR \u03b1 activation by 1H-pyrazolo-[3,4-b] pyridine derivatives. Sci Rep 2020;10:7623.","journal-title":"Sci Rep"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-3832-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-025-3832-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-3832-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:22:01Z","timestamp":1758720121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-025-3832-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["3832"],"URL":"https:\/\/doi.org\/10.1007\/s11655-025-3832-y","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,14]]},"assertion":[{"value":"10 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}